NCT02270242View on ClinicalTrials.gov

Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention

PHASE4CompletedINTERVENTIONAL

Enrollment

9,006

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 10, 2019

Study Completion Date

July 10, 2019

Conditions

Cardiovascular DiseaseInterventional Cardiology

Interventions

DRUG

Aspirin

DRUG

Placebo

DRUG

ticagrelor

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER